pyrroles has been researched along with Angiomatosis Retinae in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, T; Hashimoto, R; Igarashi, H; Inoue, K; Ito, T; Karashima, T; Kawabe, K; Miki, M; Ogawa, Y; Ohishi, Y; Yamasaki, I | 1 |
| Jiang, CY; Wang, HW; Wang, W | 1 |
| Basso, U; Bezzon, E; Brunello, A; Maruzzo, M; Opocher, G; Pomerri, F; Roma, A; Zagonel, V; Zamarchi, R; Zovato, S | 1 |
| Akiyama, S; Fujishima, F; Imai, H; Ishioka, C; Kobayashi, A; Komine, K; Saijo, K; Sato, N; Shimodaira, H; Shirota, H; Shuin, T; Sugiyama, S; Takahashi, M; Takahashi, S | 1 |
| Benoit, G; Benoudiba, F; Brizard, M; Caillet, V; Corréas, JM; David, P; Deveaux, S; Elaidi, R; Gaudric, A; Hammel, P; Joly, D; Le Rest, C; Méjean, A; Oudard, S; Richard, S; Timsit, MO | 1 |
| Bhalla, IP; Bukowski, RM; Choueiri, TK; Elson, P; Ganapathi, R; Golshayan, AR; Jaeger, E; Rini, BI; Sein, N; Sercia, L; Simko, J; Small, EJ; Vaziri, SA; Waldman, FM; Weinberg, V; Wood, L; Zhou, M | 1 |
| Cabanillas, ME; Jimenez, C; Jonasch, E; Kyle, KL; Lano, EA; Matin, SF; Nunez, RF; Perrier, ND; Phan, A; Rich, TA; Santarpia, L; Shah, B; Waguespack, SG; Williams, MD | 1 |
| Abel, EJ; Culp, SH; Karam, JA; Margulis, V; Tamboli, P; Wang, H; Wood, CG; Zhang, XY | 1 |
| Davis, DW; Fuller, GN; Gombos, DS; Jonasch, E; Matin, SF; McCutcheon, IE; Smith, LA; Tannir, NM; Waguespack, SG; Wen, S | 1 |
| Aiello, LP; Cahill, MT; Cavallerano, J; George, DJ; Hannah, AL; Kaelin, WG; Wong, JS | 1 |
| Erginay, A; Gaudric, A; Girmens, JF; Massin, P; Richard, S; Scigalla, P | 1 |
| Adams, C; Braybrooke, JP; Cattell, E; Deplanque, G; Frith, P; Harris, AL; Huson, SM; Madhusudan, S; Moore, N; Price, P; Scigalla, P; Taylor, M; Tsaloumas, MD | 1 |
| de Wit, M; Fiedler, W; Höltje, J; Hossfeld, DK; Jacobs, MS; Laack, E; Schilling, G; Schuch, G; Scigalla, P | 1 |
| Chew, K; Fong, K; Jaeger, E; Rini, BI; Sein, N; Simko, J; Small, EJ; Waldman, FM; Weinberg, V | 1 |
| Gascón, P; Mellado, B | 1 |
| Fukata, S; Iiyama, T; Inoue, K; Karashima, T; Kawada, C; Kurabayashi, A; Shuin, T | 1 |
| Linehan, WM; Novakovic, KR; Pinto, PA; Vira, MA | 1 |
| Harris, AL | 1 |
| Aghakhani, N; Casadeval, N; Croisille, L; David, P; Eschwège, P; Gaudric, A; Hermine, O; Richard, S; Scigalla, P; Yvart, J | 1 |
3 review(s) available for pyrroles and Angiomatosis Retinae
| Article | Year |
|---|---|
Molecular biology of renal cell carcinoma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Carcinoma, Renal Cell; Exons; Humans; Indoles; Kidney Neoplasms; Molecular Biology; Mutation; Niacinamide; Phenylurea Compounds; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyridines; Pyrroles; raf Kinases; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sirolimus; Sorafenib; Sunitinib; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2006 |
Genetic basis of kidney cancer: a model for developing molecular-targeted therapies.
Topics: Adult; Aged; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Leiomyomatosis; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Sorafenib; Sunitinib; von Hippel-Lindau Disease | 2007 |
von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapy.
Topics: Angiogenesis Inhibitors; Endothelial Growth Factors; Enzyme Inhibitors; Genes, Tumor Suppressor; Germ-Line Mutation; Humans; Indoles; Lymphokines; Neovascularization, Pathologic; Protein Isoforms; Protein-Tyrosine Kinases; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Mitogen; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; von Hippel-Lindau Disease | 2000 |
4 trial(s) available for pyrroles and Angiomatosis Retinae
| Article | Year |
|---|---|
Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Renal Cell; Female; France; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms; Prospective Studies; Pyrroles; Sunitinib; Survival Analysis; Treatment Outcome; von Hippel-Lindau Disease | 2016 |
Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease.
Topics: Adult; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Hemangioblastoma; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pilot Projects; Pyrroles; Radiography; Sunitinib; Treatment Outcome; von Hippel-Lindau Disease; Young Adult | 2011 |
Antiangiogenic therapy for von Hippel-Lindau disease.
Topics: Adult; Angiogenesis Inhibitors; Brain Neoplasms; Female; Hemangioblastoma; Humans; Indoles; Male; Middle Aged; Pyrroles; Retinal Neoplasms; Spinal Cord Neoplasms; Treatment Outcome; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2004 |
Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy.
Topics: Adult; Angiogenesis Inhibitors; Enzyme Inhibitors; Female; Hematocrit; Humans; Indoles; Kinetics; Male; Middle Aged; Polycythemia; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; von Hippel-Lindau Disease | 2002 |
12 other study(ies) available for pyrroles and Angiomatosis Retinae
| Article | Year |
|---|---|
An Advanced Well-differentiated Pancreatic Neuroendocrine Carcinoma (NET-G3) Associated with Von Hippel-Lindau Disease.
Topics: Antineoplastic Agents; Asian People; Carcinoma, Neuroendocrine; Everolimus; Female; Humans; Indoles; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Pyrroles; Sunitinib; Treatment Outcome; von Hippel-Lindau Disease | 2018 |
Use of sunitinib in a 30-year-old woman with pancreatic neuroendocrine tumors associated with Von Hippel-Lindau syndrome.
Topics: Adult; Antineoplastic Agents; Female; Humans; Indoles; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Sunitinib; von Hippel-Lindau Disease | 2015 |
First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Radiography; Retrospective Studies; Sunitinib; von Hippel-Lindau Disease | 2015 |
Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease.
Topics: Adenoma, Islet Cell; Adult; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Administration Schedule; Fatal Outcome; Genes, Tumor Suppressor; Germ-Line Mutation; Humans; Indoles; Kidney Neoplasms; Male; Pancreatic Neoplasms; Pyrroles; Signal Transduction; Sunitinib; Time Factors; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2016 |
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Axitinib; Benzenesulfonates; Bevacizumab; Carcinoma, Renal Cell; Chi-Square Distribution; DNA Primers; Female; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Logistic Models; Male; Middle Aged; Mutation; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Sorafenib; Sunitinib; Survival Rate; Treatment Outcome; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2008 |
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Topics: Adrenal Gland Neoplasms; Adult; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Drug Delivery Systems; Female; Humans; Indoles; Neoplasms, Multiple Primary; Pheochromocytoma; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Treatment Outcome; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2009 |
Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Disease Models, Animal; DNA Fingerprinting; Everolimus; Female; Humans; Immunosuppressive Agents; Indoles; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Polymorphism, Single Nucleotide; Pyrroles; Sirolimus; Sunitinib; Transfection; Tumor Cells, Cultured; von Hippel-Lindau Disease; Xenograft Model Antitumor Assays | 2011 |
Rapid and durable recovery of visual function in a patient with von hippel-lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416.
Topics: Angiogenesis Inhibitors; Contrast Sensitivity; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Indoles; Magnetic Resonance Imaging; Middle Aged; Optic Disk; Optic Nerve Neoplasms; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Recovery of Function; Visual Acuity; Visual Fields; von Hippel-Lindau Disease | 2002 |
Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.
Topics: Adult; Angiogenesis Inhibitors; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Indoles; Infusions, Intravenous; Macular Edema; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Retinal Neoplasms; Visual Acuity; von Hippel-Lindau Disease | 2003 |
Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416.
Topics: Angiogenesis Inhibitors; Biopsy, Needle; Cerebellar Neoplasms; Diagnosis, Differential; Follow-Up Studies; Hemangioblastoma; Humans; Immunohistochemistry; Indoles; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrroles; Risk Assessment; Treatment Outcome; von Hippel-Lindau Disease | 2005 |
Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Bevacizumab; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Mutation; Pyrroles; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease | 2006 |
Blockade of the vascular endothelial growth factor-receptor 2 pathway inhibits the growth of human renal cell carcinoma, RBM1-IT4, in the kidney but not in the bone of nude mice.
Topics: Animals; Bone and Bones; Carcinoma, Renal Cell; Cell Proliferation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Indoles; Kidney; Kidney Neoplasms; Loss of Heterozygosity; Mice; Mutation; Oxindoles; Propionates; Pyrroles; Radiography; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 2007 |